Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...

Merck surged 3.35%, indicating a bullish trend as it challenged the $83.00 resistance mark. The stock's ascent is backed by ...

Even though Merck & Co., Inc.'s ( NYSE:MRK ) recent earnings release was robust, the market didn't seem to notice.

Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that ...

REPORTS SHARE STAKE OF 39,400 SHARES IN DISNEY- SEC FILING * REPORTS SHARE STAKE OF 44,600 SHARES IN MERCK * DISSOLVES SHARE ...

Merck & Co., Inc. has kicked off two Phase 3 trials for its experimental PrEP therapy, MK-8527. **The trials, EXPrESSIVE-10 ...

Thursday, August 14, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Merck & Co.

Merck KGaA is in the investment-grade market Tuesday, a day after holding investor calls, to help fund its $3.9 billion ...

Merck & Co., Inc. (NYSE: MRK) is one of the best depressed stocks to buy in 2025. On August 2, the company completed the ...

Merck & Co on Tuesday announced job and cost cuts that it said will save $3 billion a year, after it posted lower second-quarter results due to persistently weak demand for its Gardasil vaccine in ...

Merck & Co.’s COVID-19 pill was cleared by U.S. regulators Thursday, giving high-risk American patients a second at-home treatment just as the omicron variant is causing cases to surge around ...

Rival antiviral pills from Pfizer Inc. and Merck & Co. that demonstrated efficacy in trials of adults with COVID-19 who are at high risk of serious illness are now both in use.